Celebrity Inventors
Superstar singer Michael Jackson co-patented a "Method and means for creating anti-gravity illusion" in 1993.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 8044239 | Partially fluorinated ureas and amides One aspect of the invention is a compound of formula (I) Ro-[L-(CqH2qS)pCrH2rRf]2 (I) wherein Ro is a divalent organic group having 2 to 40 ca... | 10/25/2011 |
| 7232923 | Method of hydroaminating N-alkenoylcarbamates with primary aromatic amines The invention provides methods for hydroaminating N-alkenoyl carbamates with aromatic amines. ... | 06/19/2007 |
| 6927271 | Hydroxyl and carbamate functional resins Coating compositions contain hydroxyl- or carbamate functional resins with a relatively low equivalent weight. The resins are based on a polyol core containing urea and hydroxyl groups, and made by reacting a polyisocyanate, preferably a triisocyanate, with an amino... | 08/09/2005 |
| 6734321 | Organic articles The invention relates to novel composite materials comprising (a) an inorganic or organic bulk material having covalently bound to its surface initiator moieties for radical polymerization; and (b) a hydrophilic surface coating obtainable by applying one or more dif... | 05/11/2004 |
| 6730784 | Urea derivatives useful as synthetic intermediates Objects of the present invention are to create compounds having urea structure as basic structure and having a sulfur atom and an amide bond in side chains and to find pharmacological effects thereof, particularly TNF-α production inhibitory effects. The pre... | 05/04/2004 |
| 6683200 | N-substituted-N'-substituted urea derivatives and pharmaceutical compositions containing the derivatives N-Substituted-N'-substituted urea derivatives represented by the following formula, analogs thereof or pharmaceutically acceptable salts thereof are herein provided. These compounds show a TNF- production inhibitory activity. ##STR1##... | 01/27/2004 |
| 6552092 | Defoamers for aqueous media The invention relates to compositions for defoaming aqueous media, comprising as defoamers urea derivatives of the formula I ##STR1## where R1 --is a hydrocarbon radical, preferably having 4 to 30 carbon atoms or a hydrocarbon radical, preferab... | 04/22/2003 |
| 6531499 | Matrix metalloproteinase inhibitors and method of using same Peptoid compounds of Formula I and Formula II are disclosed ##STR1## The compounds are useful in the treatment of matrix metalloproteinase-mediated disorders.... | 03/11/2003 |
| 6492370 | Urea derivatives and pharmaceutical compositions thereof Objects of the present invention are to create compounds having urea structure as basic structure and having a sulfur atom and an amide bond in side chains and to find pharmacological effects thereof, particularly TNF- production inhibitory effects... | 12/10/2002 |
| 6406691 | Potentiator of Bacillus pesticidal activity The present invention relates to a factor that potentiates the pesticidal activity of a Bacillus related pesticide as well as methods for isolating and identifying said factor. The invention further relates to pesticidal compositions comprising the factor... | 06/18/2002 |
| 6355829 | Aspartate-terminated urea/urethane prepolymers and their use in coating compositions The present invention relates to aspartate-terminated urea/urethane prepolymers that are based on the reaction products of NCO prepolymers with compounds corresponding to the formula ##STR1## wherein X represents an organic group which has a valency of n ... | 03/12/2002 |
| 6353135 | Method for making a tetraketimine Aliphatic tetraketimine of the present invention are a novel class of compounds represented by the formula: ##STR1## wherein Et is ethyl, Me is methyl, and R is a residue of an aliphatic diisocyanate. The tetraketimine is made by condensing a novel ketimi... | 03/05/2002 |
| 6294694 | Matrix metalloproteinase inhibitors and method of using same Peptoid compounds of Formula I and Formula II are disclosed ##STR1## The compounds are useful in the treatment of matrix metalloproteinase-mediated disorders.... | 09/25/2001 |
| 6291711 | Guanylurea dinitramide, an explosive, propellant, rocket motor charge and gas generator A new chemical compound suitable for use as an explosive consists of guanylurea dinitramide having the formula ##STR1## which is also suitable as a main essential component for explosives, especially propellants; a pressed rocket motor charge; and a ... | 09/18/2001 |
| 6180745 | Moisture-curable compositions containing isocyanate and succinyl urea groups The present invention relates to moisture-curable compositions which have a) a content of (cyclo)aliphatically-bound isocyanate groups (calculated as NCO, MW 42) of 0.2 to 22% by weight and b) a content of succinyl urea groups (calculated as --NH--CO--N--, MW 57) ... | 01/30/2001 |
| 6110925 | Antibiotic for methicillin resistant bacteria The present invention is directed to anti-bacterial and anti-tumor agents and the synthesis thereof.... | 08/29/2000 |
| 6034124 | Fungicidal toxins from biocontrol bacteria A biocontrol bacteria, Bacillus cereus ATCC 53522, has been found to naturally synthesize two antibiotics, here designated zwittermicin A and antibiotic B. Zwittermicin A is a 396 dalton linear aminopolyol, a class of metabolite previously unknown in B. c... | 03/07/2000 |
| 6008410 | Ketimine Aliphatic tetraketimine of the present invention are a novel class of compounds represented by the formula: ##STR1## wherein Et is ethyl, Me is methyl, and R is a residue of an aliphatic diisocyanate. The tetraketimine is made by condensing a novel k... | 12/28/1999 |
| 5985824 | Methods and compositions for treating cystic fibrosis Methods and compositions for treating CF by mobilizing mutant forms of CFTR, which retain at least some functional activity, to the plasma membrane where they can mediate chloride ion transport are disclosed.... | 11/16/1999 |
| 5968992 | Reduction of the amine content of recycled polyols In a process for reducing the primary amine content of a composition comprising at least one polyol, in which a composition comprising at least one polyol is admixed with at least one isocyanate which contains only secondary and/or tertiary, aliphatically... | 10/19/1999 |
| 5952386 | Dihalopropene compounds, insecticides containing them as active ingredients, and intermediates for their production The present invention provides dihalopropene compounds of the general formula: ##STR1## wherein R1 is C1 -C10 alkyl or the like; L is C(.dbd.O)NH or the like; R2, R3 and R4 are indepen... | 09/14/1999 |
| 5939466 | Poly-unsaturated carbohydrate derivatives, polymers thereof and their use The present invention relates to polymerizable derivatives of carbohydrates comprising a carbohydrate radical and more than one radically polymerizable hydrocarbon group which is linked optionally via a spacer to the carbohydrate radical, to homopolymers,... | 08/17/1999 |
| 5912314 | Reaction product of mixed uretdiones and a disecondary diamine A Polyaddition product, containing uretdione groups, which is obtainable by reaction of (A) a diisocyanate mixture which contains uretdione groups and comprises (1) at least 40 mol % to not more than 80 mol % of isophorone diisocyanate containing uretdion... | 06/15/1999 |
| 5869653 | Hydrogenation of nitriles to produce amines An improved process for the catalytic hydrogenation of nitriles. The basic process comprises contacting the nitrile with hydrogen in the presence of a sponge or Raney cobalt catalyst under conditions for effecting conversion of the nitrile group to the pr... | 02/09/1999 |
| 5852054 | Fungicidal toxins from biocontrol bacteria A biocontrol bacteria, Bacillus cereus ATCC 53522, has been found to naturally synthesize two antibiotics, here designated zwittermicin A and antibiotic B. Zwittermicin A is a 396 dalton linear aminopolyol, a class of metabolite previously unknown in B. c... | 12/22/1998 |
| 5834421 | Methods and compositions for treating cystic fibrosis Methods and compositions for treating CF by mobilizing mutant forms of CFTR, which retain at least some functional activity, to the plasma membrane where they can mediate chloride ion transport are disclosed.... | 11/10/1998 |
| 5824711 | N,N,N'-trimethylbis (Aminoethyl) ether substituted urea compostions for the production of polyurethanes A method for preparing a polyurethane foam which comprises reacting an organic polyisocyanate and a polyol in the presence of a blowing agent, a cell stabilizer and a catalyst composition consisting essentially of the compound represented by the following... | 10/20/1998 |
| 5744640 | Fluorine rubber composition A fluorine rubber composition comprising a fluorine rubber and a polyfluoroalkyl group-containing block isocyanate compound represented by the following general formula: Rf(CH2)nXCONHRNHCOO(N.dbd.C--R2)mR1 where Rf is a polyflu... | 04/28/1998 |
| 5716980 | Alcohol or aldehyde derivatives and their use The present invention provides a cathepsin L inhibitor containing a compound of the formula: ##STR1## wherein R1 is a hydrogen atom or an arylalkyl, heterocyclic-alkyl or lower alkyl group which may be substituted; R2 and R... | 02/10/1998 |
| 5703076 | Retroviral protease inhibitors Urea-containing hydroxyethylamine compounds are effective as retroviral protease inhibitors, and in particular as inhibitors of HIV protease.... | 12/30/1997 |
| 5691366 | Nitro compounds, process for preparation thereof and use thereof A new nitro compound of the formula: ##STR1## wherein R1 and R2 are each lower alkyl or lower alkoxy(lower)-alkyl, or ##STR2## is cyclized to form ##STR3## X is --O--, --S-- or --NH--, m is an integer 0 or 1, and... | 11/25/1997 |
| 5637769 | Urea-modified carbodiimide and process for production thereof The present invention provides: a urea-modified carbodiimide represented by the following general formula ##STR1## (wherein each R is a C1 -C12 alkyl group or a C3 -C10 cycloalkyl group; each Z is a C1... | 06/10/1997 |
| 5637613 | 15-deoxyspergualin analogs, their method of preparation and their use in therapeutics The present invention relates, by way of novel industrial products, to compounds which are structurally related to 15-deoxyspergualin and which have the formula ##STR1## in which: A is a single bond, a group --CH2 --, a group --CH2 | 06/10/1997 |
| 5622949 | Retroviral protease inhibitors Urea-containing hydroxyethylamine peptide compounds are effective as retroviral protease inhibitors, and in particular as inhibitors of HIV protease.... | 04/22/1997 |
| 5614522 | Retroviral protease inhibitors Urea-containing hydroxyethylamine compounds are effective as retroviral protease inhibitors, and in particular as inhibitors of HIV protease.... | 03/25/1997 |
| 5610190 | Retroviral protease inhibitors Urea-containing hydroxyethylamine compounds are effective as retroviral protease inhibitors, and in particular as inhibitors of HIV Protease.... | 03/11/1997 |
| 5602275 | Urethanes and ureas that induce cytokine production The invention relates to novel ureas and urethanes of Formula I: ##STR1## which stimulate cytokine production and may be used to accelerate recovery from neutropenia accompanying radio- or chemotherapy, bone marrow transplantation, or infections. Com... | 02/11/1997 |
| 5594149 | Process for producing 1,3-dialkyl-2-imidazolidinone A novel bis-urea compound, preparation process of the compound, and preparation process of 1,3-dialkyl-2-imidazolidinone are disclosed and the disclosure provides a novel preparation process of 1,3-dialkyl-2-imidazolidinone and simultaneously enables effe... | 01/14/1997 |
| 5583256 | Process for producing 1,3-dialkyl-2-imidazolidinone A novel bis-urea compound, preparation process of the compound, and preparation process of 1,3-dialkyl-2-imidazolidinone are disclosed and the disclosure provides a novel preparation process of 1,3-dialkyl-2-imidazolidinone and simultaneously enables effe... | 12/10/1996 |
| 5510349 | Retroviral protease inhibitors Urea-containing hydroxyethylamine compounds are effective as retroviral protease inhibitors, and in particular as inhibitors of HIV protease.... | 04/23/1996 |
